[Comparative effectiveness and tolerance of combantrin and vermox in intestinal helminthiases].
D000293:Adolescent; D000328:Adult; D001562:Benzimidazoles / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D008463:Mebendazole / Q000008:administration & dosage*; D008875:Middle Aged; D011715:Pyrantel / Q000031:analogs & derivatives*; D011716:Pyrantel Pamoate / Q000008:administration & dosage*; D013535:Suspensions; D013607:Tablets
D001562:Benzimidazoles; D013535:Suspensions; D013607:Tablets; D011715:Pyrantel; D011716:Pyrantel Pamoate; D008463:Mebendazole
Sravnitel'naia éfektivnost' i perenosimost' kombantrina i vermoksa pri kishechnykh gel'mintozakh.